ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
3SBio Inc. received milestone payment of USD 4 million upon commencement of phase III clinical program of SEL-212 prnasia
November 24, 2020Chinese leading biopharmaceutical company, 3SBio Inc., announced today that Selecta Biosciences, Inc., the Company's partner, has commenced the phase III clinical program of a combination therapy involving SEL-212 for the treatment of ... -
Selecta lays off staff as R&D cash crunch looms fiercebiotech
January 07, 2019Selecta Biosciences is?laying off?more than one-third of its workforce. The cuts come as Selecta seeks to eke out its cash reserves and advance a gout drug that disappointed investors in phase 2......
Pharma Sources Insight July 2025
